Similarly, exposing Wegovy to temperatures above 86F (30C) can also lead to degradation
Some people experience nausea, stomach upset, or more serious complications
In some individuals, particularly early in treatment, there are reports of transient mild elevations in liver enzymes
More recently, metabolic cage studies have confirmed that the increased oxygen consumption and energy expenditure effect of OXM is mediated through glucagon receptor signalling ( To characterise the effects of OXM on glucose metabolism, Du and colleagues performed hyperglycaemic clamp studies in mice treated with OXM and OXMQ3E ( Rationale for GLP-1/Glucagon Combination Therapy for Weight Loss Although significant progress was made in understanding the potential use of the endogenous GLP-1/glucagon co-agonist OXM as a weight loss therapeutic in the early 2000s, evidence from various pre-clinical and human studies prior to this demonstrated the distinct mechanisms of weight loss afforded by these hormones
Glucagon-Like Peptide-1 Receptor Agonists and Risk for Ischemic Optic Neuropathy: A Target Trial Emulation by Kamika R
Eat more fiber, stay regular